These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
120 related articles for article (PubMed ID: 9972593)
1. [Combination of risperidone and serotonergic antidepressants in refractory obsessive-compulsive disorder]. Salmerón JM; Alcántara AG; Barcia D Actas Luso Esp Neurol Psiquiatr Cienc Afines; 1998; 26(6):399-402. PubMed ID: 9972593 [TBL] [Abstract][Full Text] [Related]
2. Low-dose risperidone augmentation of fluvoxamine treatment in obsessive-compulsive disorder: a double-blind, placebo-controlled study. Erzegovesi S; Guglielmo E; Siliprandi F; Bellodi L Eur Neuropsychopharmacol; 2005 Jan; 15(1):69-74. PubMed ID: 15572275 [TBL] [Abstract][Full Text] [Related]
3. Risperidone in the treatment of affective illness and obsessive-compulsive disorder. Jacobsen FM J Clin Psychiatry; 1995 Sep; 56(9):423-9. PubMed ID: 7545159 [TBL] [Abstract][Full Text] [Related]
4. A case report of refractory obsessive-compulsive disorder improved by risperidone augmentation of clomipramine treatment. Kawahara T; Ueda Y; Mitsuyama Y Psychiatry Clin Neurosci; 2000 Oct; 54(5):599-601. PubMed ID: 11043813 [TBL] [Abstract][Full Text] [Related]
5. Reduced short-term obsessive-compulsive symptoms in schizophrenic patients treated with risperidone: a single-blind prospective study. Veznedaroglu B; Ercan ES; Kayahan B; Varan A; Bayraktar E Hum Psychopharmacol; 2003 Dec; 18(8):635-40. PubMed ID: 14696023 [TBL] [Abstract][Full Text] [Related]
6. Antipsychotic augmentation of serotonergic antidepressants in treatment-resistant obsessive-compulsive disorder: a meta-analysis of the randomized controlled trials. Skapinakis P; Papatheodorou T; Mavreas V Eur Neuropsychopharmacol; 2007 Jan; 17(2):79-93. PubMed ID: 16904298 [TBL] [Abstract][Full Text] [Related]
7. Risperidone-induced obsessive-compulsive symptoms in two children. Diler RS; Yolga A; Avci A; Scahill L J Child Adolesc Psychopharmacol; 2003; 13 Suppl 1():S89-92. PubMed ID: 12880504 [TBL] [Abstract][Full Text] [Related]
8. Risperidone as monotherapy for a patient with obsessive compulsive disorder comorbid with schizoaffective disorder: a case report. Chiou YJ; Lin PY; Lee Y Clin Neuropharmacol; 2015; 38(3):114-6. PubMed ID: 25970281 [TBL] [Abstract][Full Text] [Related]
9. A double-blind, placebo-controlled study of risperidone addition in serotonin reuptake inhibitor-refractory obsessive-compulsive disorder. McDougle CJ; Epperson CN; Pelton GH; Wasylink S; Price LH Arch Gen Psychiatry; 2000 Aug; 57(8):794-801. PubMed ID: 10920469 [TBL] [Abstract][Full Text] [Related]
10. Successful treatment for obsessive-compulsive disorder with addition of low-dose risperidone to fluvoxamine: implications for plasma levels of catecholamine metabolites and serum brain-derived neurotrophic factor levels. Yoshimura R; Kaneko S; Shinkai K; Nakamura J Psychiatry Clin Neurosci; 2006 Jun; 60(3):389-93. PubMed ID: 16732759 [TBL] [Abstract][Full Text] [Related]
11. Misdiagnosis and exacerbation of unusual obsessive-compulsive disorder presentation with risperidone and clozapine in an adolescent girl - A case report. Marsanić VB; Aukst-Margetić B; Grgić N; Kusmić E Coll Antropol; 2011 Jan; 35 Suppl 1():293-6. PubMed ID: 21648350 [TBL] [Abstract][Full Text] [Related]
12. A possible tetracycline-risperidone-sertraline interaction in an adolescent. Steele M; Couturier J Can J Clin Pharmacol; 1999; 6(1):15-7. PubMed ID: 10465861 [TBL] [Abstract][Full Text] [Related]
13. Use of atypical antipsychotics in refractory depression and anxiety. Nemeroff CB J Clin Psychiatry; 2005; 66 Suppl 8():13-21. PubMed ID: 16336032 [TBL] [Abstract][Full Text] [Related]
14. Anti-androgenic treatment of obsessive-compulsive disorder: an open-label clinical trial of the long-acting gonadotropin-releasing hormone analogue triptorelin. Eriksson T Int Clin Psychopharmacol; 2007 Jan; 22(1):57-61. PubMed ID: 17159461 [TBL] [Abstract][Full Text] [Related]